Forbion European Acquisition Corp. (FRBNU) Prices Upsized $110M IPO

Forbion European Acquisition Corp. announced the pricing of its upsized $110 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FRBNU” Friday, December 10.

The new SPAC intends to combine with a promising late-stage company in the life sciences industry in Europe. Forbion European is led by CEO Jasper Bos and CFO Cyril Lesser.

Total SPAC deal count for 2021 year-to-date is now 587. This offering is expected to close on Tuesday, December 14.

UBS Investment Bank and Kempen & Co. are acting as the joint book-running managers of the offering. Davis Polk & Wardwell London LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.